# Validus Cellular Therapeutics, Inc. — Form D

Validus Cellular Therapeutics, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-11. The offering totals $2.0M, of which $25K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2022-01-11
- Form: D
- Accession: 0001820379-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $25K
- Remaining: $2.0M
- Investors: 1
- Date of first sale: 2021-11-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-428819

## Issuer

- Name: Validus Cellular Therapeutics, Inc.
- CIK: 0001820379
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12635 E MONTVIEW BLVD., AURORA, CO, 80045
- Phone: 720-767-0350

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Steven Dow | Director | Aurora, CO |
| Frank Barry | Director | Los Angeles, CA |
| Ethan Mann | Director | Aurora, CO |
| Ethan Mann | Executive Officer | Aurora, CO |
| Mike Handley | Director | Aurora, CO |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-06](https://search.stillhousedata.com/formd/0001820379-22-000002) | D | $500K | $70K |
| [2020-08-11](https://search.stillhousedata.com/formd/0001820379-20-000001) | D | $500K | $20K |

## More

- [CIK 1820379 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1820379&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001820379-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.